Steven Ades

2.1k total citations
41 papers, 743 citations indexed

About

Steven Ades is a scholar working on Pulmonary and Respiratory Medicine, Internal Medicine and Oncology. According to data from OpenAlex, Steven Ades has authored 41 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 13 papers in Internal Medicine and 13 papers in Oncology. Recurrent topics in Steven Ades's work include Venous Thromboembolism Diagnosis and Management (13 papers), Gastric Cancer Management and Outcomes (6 papers) and Esophageal Cancer Research and Treatment (5 papers). Steven Ades is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (13 papers), Gastric Cancer Management and Outcomes (6 papers) and Esophageal Cancer Research and Treatment (5 papers). Steven Ades collaborates with scholars based in United States, Canada and Japan. Steven Ades's co-authors include Chris E. Holmes, Mary Cushman, Yiyun Tang, Gregory A. Otterson, Liza C. Villaruz, Jared Weiss, Michael P. Thirlwell, Keith D. Wilner, Lorenzo Ferri and Sai‐Hong Ignatius Ou and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Steven Ades

39 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Ades United States 15 295 215 187 156 138 41 743
Hans B. Rahr Denmark 17 172 0.6× 258 1.2× 334 1.8× 112 0.7× 76 0.6× 64 715
J.-M. Bréchot France 9 298 1.0× 134 0.6× 273 1.5× 144 0.9× 108 0.8× 34 794
Marianne Sinn Germany 12 195 0.7× 208 1.0× 511 2.7× 263 1.7× 44 0.3× 34 807
Nelly G. Adel United States 9 245 0.8× 155 0.7× 926 5.0× 223 1.4× 159 1.2× 27 1.4k
Jennifer Scalici United States 19 164 0.6× 241 1.1× 321 1.7× 80 0.5× 354 2.6× 59 1.6k
Ho‐Young Yhim South Korea 17 128 0.4× 167 0.8× 361 1.9× 244 1.6× 86 0.6× 116 1.2k
Orly Leiva United States 16 103 0.3× 90 0.4× 120 0.6× 203 1.3× 152 1.1× 70 906
Nicole Princic United States 15 120 0.4× 85 0.4× 182 1.0× 115 0.7× 24 0.2× 59 672
Dong‐Hoe Koo South Korea 22 604 2.0× 372 1.7× 435 2.3× 31 0.2× 185 1.3× 88 1.1k
Jenny M. Whitworth United States 11 56 0.2× 129 0.6× 195 1.0× 86 0.6× 65 0.5× 22 549

Countries citing papers authored by Steven Ades

Since Specialization
Citations

This map shows the geographic impact of Steven Ades's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Ades with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Ades more than expected).

Fields of papers citing papers by Steven Ades

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Ades. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Ades. The network helps show where Steven Ades may publish in the future.

Co-authorship network of co-authors of Steven Ades

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Ades. A scholar is included among the top collaborators of Steven Ades based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Ades. Steven Ades is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ganguly, Eric K., et al.. (2024). Venous thromboembolism in patients with pancreatic adenocarcinoma: Disease burden and initiation of ambulatory thromboprophylaxis. Pancreatology. 24(6). 894–898. 1 indexed citations
2.
Ades, Steven, et al.. (2024). Venous thromboembolism prevention program implementation in a community oncology practice: a cohort study. The Lancet Regional Health - Americas. 38. 100866–100866. 3 indexed citations
3.
Farina, Nicholas H., H. James Wallace, Steven Ades, et al.. (2024). A MicroRNA Approach to Evaluating Elevated Prostate Cancer Risk in Cancer-Free Men. Critical Reviews in Eukaryotic Gene Expression. 34(6). 61–69.
4.
Ades, Steven & Chris E. Holmes. (2023). Implementing guidelines to prevent cancer associated thrombosis: how can we do better?. Research and Practice in Thrombosis and Haemostasis. 7(1). 100038–100038. 8 indexed citations
5.
Ades, Steven, et al.. (2023). A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma. Cancer Medicine. 12(12). 13100–13110. 6 indexed citations
6.
Feldman, Heather, et al.. (2023). Implementation of a cancer-associated thrombosis prevention program at a rural cancer center. Research and Practice in Thrombosis and Haemostasis. 8(1). 102286–102286.
7.
Lester-Coll, N.H., et al.. (2023). ‘CROSS’-ing into the ‘Real World’: a retrospective cohort study of patients receiving trimodality and bimodality therapy for esophageal cancer. Journal of Gastrointestinal Oncology. 14(2). 480–493. 2 indexed citations
8.
Anker, Christopher J., et al.. (2021). The Potential for Overtreatment With Total Neoadjuvant Therapy (TNT): Consider One Local Therapy Instead. Clinical Colorectal Cancer. 21(1). 19–35. 4 indexed citations
9.
10.
Holmes, Chris E., et al.. (2019). Risk factors for cancer‐associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE‐PACC) study. Journal of Thrombosis and Haemostasis. 17(12). 2152–2159. 15 indexed citations
11.
Farina, Nicholas H., et al.. (2018). Nanoparticle‐based targeted cancer strategies for non‐invasive prostate cancer intervention. Journal of Cellular Physiology. 233(9). 6408–6417. 8 indexed citations
12.
13.
Mori, Masanori, Yongli Ji, Santosh Kumar, Takamaru Ashikaga, & Steven Ades. (2016). Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study. International Journal of Clinical Oncology. 22(2). 397–404. 10 indexed citations
14.
Ades, Steven, Shailesh Kumar, Murad Alam, et al.. (2015). Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer. Journal of Thrombosis and Haemostasis. 13(6). 998–1003. 63 indexed citations
15.
Sudarshan, Monisha, Thierry Alcindor, Steven Ades, et al.. (2014). Survival and Recurrence Patterns after Neoadjuvant Docetaxel, Cisplatin, and 5-Fluorouracil (DCF) for Locally Advanced Esophagogastric Adenocarcinoma. Annals of Surgical Oncology. 22(1). 324–330. 16 indexed citations
16.
Lutsey, Pamela L., Christopher T. Sibley, Neil A. Zakai, et al.. (2013). Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis. Journal of Thrombosis and Haemostasis. 11(6). 1078–1084. 56 indexed citations
17.
Alcindor, Thierry, Lorenzo Ferri, Victoria Marcus, et al.. (2012). Perioperative DCF chemotherapy protocol for patients with gastroesophageal adenocarcinoma: correlation between response to treatment and outcome. Medical Oncology. 30(1). 377–377. 6 indexed citations
18.
19.
Ferri, Lorenzo, Steven Ades, Thierry Alcindor, et al.. (2011). Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial. Annals of Oncology. 23(6). 1512–1517. 80 indexed citations
20.
Ades, Steven, et al.. (2001). Lens changes in hereditary hyperferritinemia-cataract syndrome. American Journal of Ophthalmology. 132(5). 786–788. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hans B. Rahr Breakdown of academic impact, for papers by J.-M. Bréchot Breakdown of academic impact, for papers by Marianne Sinn Breakdown of academic impact, for papers by Nelly G. Adel Breakdown of academic impact, for papers by Jennifer Scalici Breakdown of academic impact, for papers by Ho‐Young Yhim Breakdown of academic impact, for papers by Orly Leiva Breakdown of academic impact, for papers by Nicole Princic Breakdown of academic impact, for papers by Dong‐Hoe Koo Breakdown of academic impact, for papers by Jenny M. Whitworth
Rankless by CCL
2026